Everest Medicines to Announce 2025 Full-Year Financial Results on March 26, 2026

2026-03-10 - 11:36

SHANGHAI, March 10, 2026 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its financial results for the full year ended December 31, 2025, and provide a business update on March 26, 2026.